Plasmid DNA Manufacturing

Plasmid DNA Manufacturing Market Will Register a CAGR of Nearly 21.7% by 2030 Plasmid DNA Manufacturing Market Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 - 2030

Share This Article

As per the experts, the plasmid DNA manufacturing market is predicted to record a growth rate of 21.7% from 2021-2030 and is projected to reach US$ 2.1 billion by 2030.

The study provides the overall revenue of the global plasmid DNA manufacturing market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global plasmid DNA manufacturing market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the plasmid DNA manufacturing industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1299

Crucial factors accountable for market growth are:

  • Growing burden of cancer cases
  • Growing prevalence of disease
  • Growing geriatric population
  • Heavy investments on technology and innovations
  • Rising government expenditure on healthcare sector in emerging economies
  • Rapid growth of the biopharmaceutical industry
  • Growing popularity of gene therapy amongst the consumer/patients

Report Highlights

  • By product type, the viral vector segment led the global plasmid DNA manufacturing market with remarkable revenue share in 2020. The demand for the viral vector in the production of vaccines, cell therapies, and gene therapies is already very huge across the globe. The COVID-19 pandemic further boosted its increasing demand for the vaccine production.
  • By application, the gene therapy segment led the global plasmid DNA manufacturing market with remarkable revenue share in 2020.This is because of the growing confidence of the people regarding the effectiveness, reliability, and safety of the gene therapies in the treatment of various chronic and genetic diseases.
  • By disease, the cancer segment is expected to be the fastest-growing segment throughout the forecast period, owing to the increasing uses of the plasmid DNA in the development of various treatment therapies for the cancer

Scope of the Plasmid DNA Manufacturing Market

Report Coverage Details
Market Size in 2020 USD 306.4 Million
Growth Rate from 2021 to 2030 CAGR of 21.7%
Base Year 2021
Largest Market North America
Fastest Growing Market Asia Pacific
Forecast Period 2021 to 2030
Segments Covered Product Type, Application Type, Disease Type, Regional Outlook

Regional Snapshots

North America is the leading plasmid DNA manufacturing market. The growing investments in the development of new biopharmaceutical medicines are resulting in rise in the number of contract manufacturers in the region. Moreover, US hold the maximum intellectual property copyrights for majority of the newly developed medicines. The higher adoption rate of advanced healthcare services coupled with growing preferences for gene and cell therapies among the population is a major factor that propelled the demand for the plasmid DNA manufacturing market in North America. The continuous research and development activities towards the development of new biopharma medicines are expected to foster market growth in the forthcoming years. Along with the growth of the contract manufacturers, North America is also hub for the numerous contract research organizations that facilitates development of new medicines.

Asia Pacific is expected to witness highest growth rate throughout the forecast period owing to the growing manufacturing of plasmid DNA in the region. The world’s largest contract manufacturing company, GenScript started its operation in China by setting up a plasmid and virus facility in December 2019. This is a major development in the Asia Pacific plasmid DNA manufacturing market. Furthermore, the presence of Biocon in India and Samsung Biologics in South Korea are witnessing spike in their sales in the past few years. These factors are expected to boost the plasmid DNA manufacturing market in the region.

Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2021 – 2030.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the plasmid DNA manufacturing market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global plasmid DNA manufacturing market are as follows:

  • VGXI, Inc.
  • Akron Biotech
  • Cobra Biologics & Pharmaceutical Services
  • Aldevron
  • Plasmidfactory GmbH
  • Vigene Biosciences
  • Luminous Biosciences
  • Nature Technology Corporation
  • Delphi Genetics
  • JAFRAL Ltd.

Segments Covered in the Report

By Product

  • Viral Vectors
  • Plasmid DNA
  • Non-Viral
  • Electroporation
  • Lipid/Polymer
  • Nanoparticles
  • Others

By Application

  • Gene Therapy
  • DNA Vaccines
  • Immunotherapy
  • Others

By Disease

  • Infectious Disease
  • Genetic Disorder
  • Cancer

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Why should you invest in this report?

If you are aiming to enter the global plasmid DNA manufacturing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for plasmid DNA manufacturing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Plasmid DNA Manufacturing Market, By Product

7.1. Plasmid DNA Manufacturing Market, by Product Type, 2021-2030

7.1.1. Viral Vectors

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Plasmid DNA

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Non-Viral

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. Electroporation

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Lipid/Polymer

7.1.5.1. Market Revenue and Forecast (2019-2030)

7.1.6. Nanoparticles

7.1.6.1. Market Revenue and Forecast (2019-2030)

7.1.7. Others

7.1.7.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Plasmid DNA Manufacturing Market, By Application

8.1. Plasmid DNA Manufacturing Market, by Application, 2021-2030

8.1.1. Gene Therapy

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Immunotherapy

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Plasmid DNA Manufacturing Market, By Disease

9.1. Plasmid DNA Manufacturing Market, by Disease, 2021-2030

9.1.1. Infectious Disease

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Genetic Disorder

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Plasmid DNA Manufacturing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.3. Market Revenue and Forecast, by Disease (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Disease (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Disease (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.3. Market Revenue and Forecast, by Disease (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Disease (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Disease (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Disease (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Disease (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.3. Market Revenue and Forecast, by Disease (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Disease (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Disease (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Disease (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Disease (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.3. Market Revenue and Forecast, by Disease (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Disease (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Disease (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Disease (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Disease (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.3. Market Revenue and Forecast, by Disease (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Disease (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Disease (2019-2030)

Chapter 11. Company Profiles

11.1. VGXI, Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Akron Biotech

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Cobra Biologics & Pharmaceutical Services

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Aldevron

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Plasmidfactory GmbH

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Vigene Biosciences

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Luminous Biosciences

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Nature Technology Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Delphi Genetics

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. JAFRAL Ltd.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1299

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →